Antithrombotics in vascular disease and renal dysfunction

Journal of the American College of Cardiology

This analysis evaluated whether the benefits of rivaroxaban 2.5 mg bd plus aspirin, comparedwith aspirin alone, are maintained in vascular patients who also have renal dysfunction.

Fracassi F, Crea F, et al.

Volume 73, Issue 18, May 2019

This study examined the prevalence,morphological features, and significance ofhealed plaques at the culprit site in patients withacute coronary syndromes usingoptical coherence tomography.

Evolocumab in patients with familial hypercholesterolaemia

This study reports the long-term efficacy and safety of the proprotein convertase subtilisin/kexintype 9(PCSK9) inhibitor evolocumabin patients with familial hypercholesterolaemia.

Stent-related adverse events beyond one year

This study examined the frequency and predictors of very late (one to five years) stent-related events or major adverse cardiovascular events by stent type.